Journal of Wound Management July Issue Out Now
The latest issue of JWM brings five new scientific papers on wound care.
EWMA Innovation Team offers support to companies within health care and medical devices assisted by our global network of high-level experts. We ensure a smooth process of the projects wherever you involve us on the value chain from innovation idea to market access.
As a non-profit association any gain from the delivery of services are used to further strengthen the innovation efforts of EWMA primarily a) the development of regional clinical collaborations and hubs to facilitate the development of integrated patient pathways and the access to perform clinical trials for industry; b) a European level wound innovation network; c) EWMA Innovation Forum, EWMA Innovation Competition and EWMA B2B match making.
EWMA Innovation Team offers the services below. Before we prepare a non-binding offer introductory meetings are held with the client to understand what specific expert competencies should be assigned for the tasks and then with the experts to discuss the tasks more in depths. These meetings are free of costs. An NDA will be signed ahead of the introductory meetings.
We align with perspectives of payers, health systems, expert end-users and patients by delivering emerging technology reviews (ETR) in collaboration with Excite International.
We assist with planning exploratory, first-in-human (FIH) trials, expert lead investigator advisory, proposals for trial site and lead investigator together with choice of CRO.
We advise on FDA and EMA requirements, analyze product health economy, create bridges to US and EU regulatory contacts and assist with medical writing and statistics.
We ensure effective communication to consumers, health care professionals and payers by user group tests, expert input, data, and stakeholder dialogue.
”EWMA Innovation Team has made a great difference for Soft Ox Solutions by contributing to our strategic considerations and our planning with respect to clinical trials and regulatory issues. In addition, EWMA Innovation Team has brought us in contact with highly respected Key Opinion Leaders, supporting and boosting our continued development, and building a platform which has made it possible to reach out to investors."
- Geir Hermod Almås, CEO
Jan Apelqvist is a senior consultant and an associate professor at the Department of Endocrinology University Hospital of Skåne in Malmö and division for clinical sciences University of Lund (Sweden) coordinating a multidisciplinary foot care centre (national centre of excellence) for prevention/ treatment of the diabetic foot. Jan is an experienced lead investigator of clinical trials in collaboration with industry.
Alberto Piaggesi is director and professor of the Diabetic Foot Section of the Pisa University Hospital, Department of Endocrinology and Metabolism, University of Pisa (Italy). He has a long-lasting surgical experience on diabetic foot conservative surgery, and he performed more than 5000 interventions in this specialty as first operator. Alberto is an experienced lead investigator of clinical trials in collaboration with industry.
Sebastian Probst is Full Professor of Tissue Viability and Wound Care, Geneva School of Health Sciences, HES-SO University of Applied Sciences and Arts Western Switzerland, Geneva, Switzerland. In addition, he is Adjunct Professor at the College of Medicine Nursing and Health Sciences at the University of Galway, Galway, Ireland. He is the Immediate Past President of the EWMA association. Sebastian Probst's output is broad ranging and covers trials consisting in innovative therapeutic approaches for wound management in patients with venous leg ulcers, targeting the management of risk factors to prevent recurrences and enhance quality of life of this patient population. in addition, he is an expert in wound care informatics.
Prof Thomas Bjarnsholt is a global expert in the role of biofilms in chronic infections, with over 250 peer reviewed publications in the biofilm field. His research focuses on biofilm formation and the role of bacterial biofilm in chronic infections, both in vitro, animal models and ex vivo material from chronic infections. Bjarnsholt is interested as to how bacteria initiate biofilms in the human body and why the immune defense seems to fail both in the initial infection and later in the chronic infection. His research also seeks to develop tools and methods to enable fast diagnosis of these infections, for better treatment and possible prevention.
Klaus Kirketerp-Møller, MD, Orthopaedic surgeon and Ph.d., heads the Copenhagen Wound Healing Center at Bispebjerg University Hospital. The CWHC is an interdisciplinary tertiary wound healing center treating all types of difficult to heal wounds, including venous leg ulcers, diabetic foot ulcers and inflammatory ulcers. The research at the center includes clinical as well as experimental research in bacterial biofilm, wound exudate, prevention and digital solutions for wound monitoring. He has been chairman of Diabetic Foot Study Group under European Association for the Study of Diabetes and European Bone and Joint Infection Society. He is co-founder of the International Association of Diabetic Foot Surgeons. He is affiliated with Steno Diabetes Center Copenhagen. He has participated in writing the IWGDF guidelines on off-loading and has been involved in development of new antimicrobial solutions and new wound dressings.
EWMA Innovation Team is a modern network-based service provider combining unique world class competencies with speed, flexibility, and full focus on meeting client requirements. EWMA Innovation Team collaborates with global top competencies and composes tailor-made teams. EWMA Innovation Team supports the assigned task specific teams and ensures a fast and meticulous process meeting timelines, milestones, and deliverables. Finally, EWMA Innovation Team ensures fast and precise communication with the clients